Breast cancer is ordered into 4 major subtypes based on the presence or absence of molecular markers for estrogen receptors (ER) or progesterone receptors (PR) and human epidermal growth factor 2 (ERBB2; formerly HER2). This evidence concerns the gene ESR1 and breast cancer.